Login to Your Account



Other News To Note


Monday, April 23, 2012
• Athersys Inc., of Cleveland, said preclinical data published in Cell Transplantation suggested MultiStem could provide benefit to patients suffering from lysosomal storage disorders such as MPS-1 disease, also known as Hurler's syndrome.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription